Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Terns Pharmaceuticals (TERN) Leases (2022 - 2025)

Terns Pharmaceuticals filings provide 4 years of Leases readings, the most recent being $837000.0 for Q4 2025.

  • Quarterly Leases fell 32.93% to $837000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $837000.0 through Dec 2025, down 32.93% year-over-year, with the annual reading at $837000.0 for FY2025, 32.93% down from the prior year.
  • Leases hit $837000.0 in Q4 2025 for Terns Pharmaceuticals, down from $938000.0 in the prior quarter.
  • Across five years, Leases topped out at $1.4 million in Q1 2022 and bottomed at $217000.0 in Q2 2024.
  • Average Leases over 4 years is $929312.5, with a median of $987500.0 recorded in 2025.
  • The largest annual shift saw Leases crashed 71.3% in 2024 before it skyrocketed 377.88% in 2025.
  • Terns Pharmaceuticals' Leases stood at $1.0 million in 2022, then plummeted by 50.05% to $523000.0 in 2023, then soared by 138.62% to $1.2 million in 2024, then tumbled by 32.93% to $837000.0 in 2025.
  • Per Business Quant, the three most recent readings for TERN's Leases are $837000.0 (Q4 2025), $938000.0 (Q3 2025), and $1.0 million (Q2 2025).